Listed Company Name: Kyowa Hakko Kirin Co., Ltd.
Representative: Nobuo Hanai, President and CEO (Code no.: 4151, First Section of TSE)
Inquiries: Shigeru Morotomi, Executive Officer Corporate Communications Department Media Contact: +81-3-3282-1903
Investor Contact: +81-3-3282-0009
Revised forecasts
Revised forecasts of consolidated results for the interim period of fiscal 2015 (January 1, 2015 to June 30, 2015)
Millions of yen | |||||
Net sales | Operating income | Ordinary income | Net income | Net income per share (¥) | |
Previous forecasts (A) | 172,000 | 16,500 | - | - | - |
Revised forecasts (B) | 178,800 | 22,400 | - | - | - |
Change in forecasts (B-A) | 6,800 | 5,900 | - | - | - |
Percentage change | 4.0 | 35.8 | - | - | - |
Reference: Results for the interim period of the fiscal year ended December 31, 2014 | 161,899 | 18,411 | 16,865 | 9,185 | 16.78 |
Revised forecasts of consolidated results for fiscal 2015 (January 1, 2015 to December 31, 2015)
Millions of yen | |||||
Net sales | Operating income | Ordinary income | Net income | Net income per share (¥) | |
Previous forecasts (A) | 354,000 | 41,500 | 34,000 | 18,500 | 33.80 |
Revised forecasts (B) | 360,000 | 47,000 | 41,000 | 26,000 | 47.51 |
Change in forecasts (B-A) | 6,000 | 5,500 | 7,000 | 7,500 | - |
Percentage change | 1.7 | 13.3 | 20.6 | 40.5 | - |
Reference: Results for the fiscal year ended December 31, 2014 | 333,446 | 36,173 | 29,511 | 15,898 | 29.05 |
In the consolidated results for the interim period, sales and operating income in the Pharmaceuticals business are higher than the initial plan. In addition, the share of loss of entities accounted for using the equity method and the income tax rate are expected to decline, influencing net income for the full year. In light of these trends, forecasts for consolidated interim and full year results have been revised upwards.
The above forecasts are based on currently available information and on certain assumptions deemed to be reasonable. Actual results may differ substantially due to a wide variety of reasons.
***ENDS***
For further information please access: http://www.kyowa-kirin.com/news_releases/index.html
distributed by |